AdvanceBio Your Oligonucleotide Workflow
Brochures and specifications | 2023 | Agilent TechnologiesInstrumentation
Synthetic oligonucleotides—including aptamers, guide RNAs, siRNAs, and antisense oligos—are increasingly central to life-science research and therapeutic development. However, effective monitoring, identification, and removal of impurities from incomplete coupling, side reactions, and post-synthesis processing remain major challenges. Robust analytical and purification workflows are critical to ensure high quality and yield of target sequences.
This document presents the Agilent AdvanceBio Oligonucleotide workflow, a fully integrated solution for analytical characterization and preparative purification of DNA and RNA oligonucleotides. It covers scalable column chemistries, mobile-phase strategies, software integration, and instrumentation enabling efficient method transfer and reduced downtime.
Ongoing and future advances may include:
The Agilent AdvanceBio Oligonucleotide workflow combines superficially porous column technology, optimized mobile-phase strategies, and integrated software to deliver high-resolution, scalable solutions for oligonucleotide analysis and purification. This platform addresses key impurity challenges, streamlines method transfer, and enhances cost efficiency, supporting the rapid development of nucleic acid therapeutics.
Consumables, LC columns
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Summary
Significance of the Topic
Synthetic oligonucleotides—including aptamers, guide RNAs, siRNAs, and antisense oligos—are increasingly central to life-science research and therapeutic development. However, effective monitoring, identification, and removal of impurities from incomplete coupling, side reactions, and post-synthesis processing remain major challenges. Robust analytical and purification workflows are critical to ensure high quality and yield of target sequences.
Objectives and Study Overview
This document presents the Agilent AdvanceBio Oligonucleotide workflow, a fully integrated solution for analytical characterization and preparative purification of DNA and RNA oligonucleotides. It covers scalable column chemistries, mobile-phase strategies, software integration, and instrumentation enabling efficient method transfer and reduced downtime.
Methods and Instrumentation
- Instrumentation
- Agilent 1290 Infinity II UHPLC System
- Agilent 6530 LC/Q-TOF Mass Spectrometer
- Agilent MassHunter BioConfirm 12.0 software for automated sequence confirmation
- Stationary Phase Details
- AdvanceBio Oligonucleotide superficially porous columns
- Particle sizes: 2.7 µm (analytical) and 4 µm (scalar/preparative)
- pH stability: 3–11; temperature up to 65 °C; pore size 120 Å; pressure tolerance 600 bar
- Internal diameters available: 2.1 mm, 4.6 mm, and 21.2 mm
- Mobile-Phase Composition
- Analytical: 15 mM triethylamine (TEA)/400 mM hexafluoroisopropanol (HFIP) in water with methanol gradient (10–40% B over 10 min)
- Preparative: Dibutylamine (DBA)/TRIS alternative to reduce HFIP usage, compatible with mass-directed fraction collection
Main Results and Discussion
- Sub-two-micron performance achieved high separation efficiency at reduced backpressure compared to fully porous particles.
- High-resolution LC/MS and UV separation of DNA ladder (15–40 mer) and RNA standards (14–21 mer) demonstrated clear baseline resolution.
- MassHunter BioConfirm 12.0 enabled automated target-peptide-ion (TPI) data processing, reducing analysis time and improving reproducibility.
- Preparative purification on 21.2 mm columns with DBA/TRIS mobile phase delivered rapid fraction collection, enhanced purity, and high recovery of target oligonucleotides.
Benefits and Practical Applications
- Seamless method scale-up from analytical to preparative workflows with minimal reoptimization.
- Dual compatibility with LC/MS and UV detection for comprehensive impurity profiling and purification.
- Reduced reliance on expensive HFIP through optimized ion-pairing reagent alternatives.
- Batch-qualified stationary phases ensure consistent performance across lots.
Future Trends and Opportunities
Ongoing and future advances may include:
- Further optimization of alternative ion-pairing reagents to lower costs and environmental impact.
- Integration of AI-driven method development and real-time data analysis for higher throughput.
- Expansion of column chemistries to accommodate longer, modified oligonucleotides and complex conjugates.
- Implementation of process analytical technology (PAT) for in-line monitoring in oligonucleotide manufacturing.
Conclusion
The Agilent AdvanceBio Oligonucleotide workflow combines superficially porous column technology, optimized mobile-phase strategies, and integrated software to deliver high-resolution, scalable solutions for oligonucleotide analysis and purification. This platform addresses key impurity challenges, streamlines method transfer, and enhances cost efficiency, supporting the rapid development of nucleic acid therapeutics.
References
- Vanhoenacker G, Lecluyse C, Debyser G, Sandra P, Sandra K. Evaluation of Different Ion-Pairing Reagents for LC/UV and LC/MS Analysis of Oligonucleotides. Agilent Technologies application note.
- Schipperges S, Schneider S, Huber U. Simplified Oligonucleotide Analysis and Characterization with AdvanceBio Oligonucleotide Columns and MassHunter BioConfirm 12.0. Agilent Technologies application note.
- Rieck F. Fast and Selective Purification of Oligonucleotides Using Preparative HPLC/MS and Software Support. Agilent Technologies application note.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC
2023|Agilent Technologies|Presentations
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC Mohit Patel LC Columns and Consumables Technical Support December 19, 2023 1 12/19/2023 DE # DE48216954 What Are Oligonucleotide Therapeutic Types? Oligonucleotides are being increasingly developed as therapeutics against a…
Key words
oligonucleotide, oligonucleotideoligonucleotides, oligonucleotidesadvancebio, advancebiopair, pairladder, ladderbuffer, bufferresolution, resolutionmau, mauion, ionrcrarcrurgrararurarcrcrararu, rcrarcrurgrararurarcrcrararurgrurcrarurcrarcrarcrurgrararurarcrcrararu, rgrurcrarurcrarcrarcrurgrararurarcrcrararururcrarcrarcrurgrararurarcrcrararu, rurcrarcrarcrurgrararurarcrcrararururcrarurcrarcrarcrurgrararurarcrcrararu, rurcrarurcrarcrarcrurgrararurarcrcrararuphase, phasebinding
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards
2015|Agilent Technologies|Brochures and specifications
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards IMPROVE RELIABILITY. REDUCE COSTS. INCREASE FLEXIBILITY. AGILENT ADVANCEBIO OLIGONUCLEOTIDE COLUMNS AND OLIGONUCLEOTIDE STANDARDS HIGH-RESOLUTION OLIGONUCLEOTIDE SEPARATIONS WITH LONG COLUMN LIFETIME ON HPLC AND UHPLC SYSTEMS Synthetic oligonucleotides are promising therapeutic agents for the…
Key words
oligonucleotide, oligonucleotideadvancebio, advancebioseparations, separationsagilent, agilentmau, mauoligonucleotides, oligonucleotidesoligo, oligolifetime, lifetimetriethylammonium, triethylammoniumrna, rnacolumns, columnsteaa, teaahexafluoroisopropanol, hexafluoroisopropanoldna, dnaresolution
Fast and Selective Purification of Oligonucleotides Using Preparative HPLC/MS and Software Support
2022|Agilent Technologies|Applications
Application Note Biopharma/Pharma Fast and Selective Purification of Oligonucleotides Using Preparative HPLC/MS and Software Support mAU UV 800 400 0 cps 80,000 2 4 6 8 10 12 min 2 4 6 8 10 12 min 2 4 6 8…
Key words
fraction, fractionpurification, purificationflp, flppreparative, preparativemsd, msdcollection, collectionmin, minhfip, hfipwere, weredba, dbacps, cpsmau, mauruns, runstrigger, triggeroligonucleotides
An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations: From Analysis to Purification
2025|Agilent Technologies|Presentations
An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations: From Analysis to Purification Melissa Goodlad, PhD Columns and Supplies Applications Engineer April 15, 2025 1 April 15, 2025 An Introduction to Ion-Paired Reverse-Phase Oligonucleotide Separations DE-006001 Introduction to Ion-Paired Reverse-Phase (IP-RP) Separations…
Key words
oligonucleotide, oligonucleotidepaired, pairedreverse, reverseseparations, separationsion, ionphase, phaseintroduction, introductioncolumn, columnoptimization, optimizationmethod, methodprep, preppurification, purificationpairing, pairingselection, selectionobjectives